Published in Clin Chim Acta on February 05, 1982
Pyruvate kinase and the "high ATP syndrome". J Clin Invest (1984) 0.77
Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol (2000) 3.49
Rapid Ca2+-mediated activation of Rap1 in human platelets. EMBO J (1997) 3.23
Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature (1986) 2.31
Concentration of rafts in platelet filopodia correlates with recruitment of c-Src and CD63 to these domains. J Thromb Haemost (2003) 2.18
Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency. N Engl J Med (1977) 2.12
Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res (1992) 2.00
c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol (1996) 1.75
Identification of connexin43 as a functional target for Wnt signalling. J Cell Sci (1998) 1.64
Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest (1978) 1.61
Relation between energy production and adenine nucleotide metabolism in human blood platelets. Biochim Biophys Acta (1980) 1.59
Activation of the small GTPase Ral in platelets. Mol Cell Biol (1998) 1.58
Hemophagocytic lymphohistiocytosis and dengue infection: rare case report. Acta Clin Belg (2014) 1.57
Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx. Proc Natl Acad Sci U S A (1994) 1.55
p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem (2000) 1.44
Activation of sodium-proton exchange is a prerequisite for Ca2+ mobilization in human platelets. Nature (1987) 1.39
p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene (1998) 1.38
Dual regulation of platelet protein kinase B. J Biol Chem (2000) 1.37
Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett (1998) 1.36
Haemorrhagic diathesis in neonatal calves: an emerging syndrome in Europe. Transbound Emerg Dis (2010) 1.34
Sequential regulation of the small GTPase Rap1 in human platelets. Mol Cell Biol (2000) 1.32
Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Acta (1969) 1.31
Human erythrocyte pyruvate kinase. Its purification and some properties. Biochim Biophys Acta (1971) 1.25
Characterization of alpha-L-fucosidase from two different families with fucosidosis. Clin Chim Acta (1976) 1.20
Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood (1987) 1.18
Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol (1998) 1.17
Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens. J Pathol (1997) 1.07
Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial. Blood (1991) 1.05
An abnormal form of purine nucleoside phosphorylase in a family with a child with severe defective T-cell-and normal B-cell immunity. Clin Chim Acta (1976) 1.03
The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions. J Thromb Haemost (2005) 1.02
Endocarditis of native aortic and mitral valves due to Corynebacterium accolens: report of a case and application of phenotypic and genotypic techniques for identification. J Clin Microbiol (1996) 1.02
Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Cancer Res (1989) 1.01
Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders. J Oral Pathol Med (1998) 1.01
Pyruvate kinase activity and isozyme composition in normal fibrous tissue and fibroblastic proliferations. Cancer (1991) 1.00
Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates. J Biol Chem (1990) 0.99
Purification and some properties of human erythrocyte hexokinase. Biochim Biophys Acta (1976) 0.99
Exposure of ligand-binding sites on platelet integrin alpha IIB/beta 3 by phosphorylation of the beta 3 subunit. Biochem J (1996) 0.99
CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes. Eur J Immunol (1999) 0.99
The reaction mechanism of glutathione reductase from human erythrocytes. Biochim Biophys Acta (1969) 0.97
Protein kinase C enhances Ca2+ mobilization in human platelets by activating Na+/H+ exchange. J Biol Chem (1988) 0.97
Metabolic energy is required in human platelets at any stage during optical aggregation and secretion. Biochim Biophys Acta (1984) 0.96
Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies. Biochem J (1985) 0.96
Glycolytic enzyme activities in breast cancer metastases. Tumour Biol (1988) 0.96
A novel technique for rapid determination of energy consumption in platelets. Demonstration of different energy consumption associated with three secretory responses. Biochem J (1983) 0.95
Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets. Biochem J (1991) 0.95
Reactome - a curated knowledgebase of biological pathways: megakaryocytes and platelets. J Thromb Haemost (2012) 0.94
Determination of levels of glycolytic intermediates and nucleotides in platelets by pulse-labeling with [32P]orthophosphate. Anal Biochem (1983) 0.94
Quantification of energy consumption in platelets during thrombin-induced aggregation and secretion. Tight coupling between platelet responses and the increment in energy consumption. Biochem J (1984) 0.94
Low-density lipoprotein enhances platelet secretion via integrin-alphaIIbbeta3-mediated signaling. Arterioscler Thromb Vasc Biol (1999) 0.94
Rapid separation of cytosol and particle fraction of human platelets by digitonin-induced cell damage. Br J Haematol (1980) 0.93
Expression of transient receptor potential mRNA isoforms and Ca(2+) influx in differentiating human stem cells and platelets. Biochim Biophys Acta (2001) 0.93
Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes. J Clin Invest (1980) 0.93
Expression of a folate binding protein in L1210 cells grown in low folate medium. Cancer Res (1989) 0.93
Inhibition of platelet integrin alpha(IIb)beta(3) by peptides that interfere with protein kinases and the beta(3) tail. Arterioscler Thromb Vasc Biol (2000) 0.92
Regulation of human erythrocyte hexokinase. The influence of glycolytic intermediates and inorganic phosphate. Biochim Biophys Acta (1977) 0.92
Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems. Cancer Res (1991) 0.92
Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. Biochem J (1984) 0.92
Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas. Cancer Res (1987) 0.91
Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch-Nyhan syndrome. Hum Genet (1981) 0.91
Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumour Biol (1987) 0.91
LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules. Arterioscler Thromb (1994) 0.91
Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor. J Biol Chem (1995) 0.90
Characterization of mutant subunits of human purine nucleoside phosphorylase. J Biol Chem (1978) 0.89
Signal transduction through trimeric G proteins in megakaryoblastic cell lines. Arterioscler Thromb Vasc Biol (1997) 0.89
Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets. J Biol Chem (1986) 0.89
The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro. J Immunol (1984) 0.89
Human platelets secrete chemotactic activity for eosinophils. Blood (1993) 0.88
Orotic aciduria in two unrelated patients with inherited deficiencies of purine nucleoside phosphorylase. J Clin Invest (1977) 0.88
Generalized hexokinase deficiency in the blood cells of a patient with nonspherocytic hemolytic anemia. Blood (1983) 0.88
Differential involvement of tyrosine and serine/threonine kinases in platelet integrin alphaIIbbeta3 exposure. Arterioscler Thromb Vasc Biol (1998) 0.88
Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Cancer Res (1989) 0.88
Compartmentation of hexokinase in human blood cells. Characterization of soluble and particulate enzymes. Biochim Biophys Acta (1982) 0.87
Platelet aggregation and Ca2+ secretion are independent of simultaneous ATP production. FEBS Lett (1979) 0.87
Isozyme pattern of enolase of childhood tumors. Cancer (1984) 0.87
The influence of glucose I,6-diphosphate on the enzymatic activity of pyruvate kinase. Biochim Biophys Acta (1972) 0.87
Na+/H+ exchange modulates Ca2+ mobilization in human platelets stimulated by ADP and the thromboxane mimetic U 46619. J Biol Chem (1990) 0.86
Regulation of carbohydrate metabolism in platelets. A review. Thromb Haemost (1978) 0.86
Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol (1998) 0.86
Standardization of an enzyme-linked immunosorbent assay for the determination of protein tyrosine kinase activity. Anal Biochem (1993) 0.86